_version_ 1784630078832902144
author Bartoletti, Michele
Azap, Ozlem
Barac, Aleksandra
Bussini, Linda
Ergonul, Onder
Krause, Robert
Martín-Quirós, Alejandro
Paño-Pardo, José Ramon
Power, Nicholas
Sibani, Marcella
Szabo, Balint
Tsiodras, Sotirios
Zollner-Schwetz, Ines
Rodriguez-Baño, Jesús
author_facet Bartoletti, Michele
Azap, Ozlem
Barac, Aleksandra
Bussini, Linda
Ergonul, Onder
Krause, Robert
Martín-Quirós, Alejandro
Paño-Pardo, José Ramon
Power, Nicholas
Sibani, Marcella
Szabo, Balint
Tsiodras, Sotirios
Zollner-Schwetz, Ines
Rodriguez-Baño, Jesús
author_sort Bartoletti, Michele
collection PubMed
description
format Online
Article
Text
id pubmed-8744251
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-87442512022-01-10 ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply Bartoletti, Michele Azap, Ozlem Barac, Aleksandra Bussini, Linda Ergonul, Onder Krause, Robert Martín-Quirós, Alejandro Paño-Pardo, José Ramon Power, Nicholas Sibani, Marcella Szabo, Balint Tsiodras, Sotirios Zollner-Schwetz, Ines Rodriguez-Baño, Jesús Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022-04 2022-01-10 /pmc/articles/PMC8744251/ /pubmed/35026374 http://dx.doi.org/10.1016/j.cmi.2021.12.025 Text en © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Bartoletti, Michele
Azap, Ozlem
Barac, Aleksandra
Bussini, Linda
Ergonul, Onder
Krause, Robert
Martín-Quirós, Alejandro
Paño-Pardo, José Ramon
Power, Nicholas
Sibani, Marcella
Szabo, Balint
Tsiodras, Sotirios
Zollner-Schwetz, Ines
Rodriguez-Baño, Jesús
ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply
title ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply
title_full ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply
title_fullStr ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply
title_full_unstemmed ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply
title_short ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply
title_sort escmid covid-19 living guidelines: drug treatment and clinical management: author's reply
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744251/
https://www.ncbi.nlm.nih.gov/pubmed/35026374
http://dx.doi.org/10.1016/j.cmi.2021.12.025
work_keys_str_mv AT bartolettimichele escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply
AT azapozlem escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply
AT baracaleksandra escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply
AT bussinilinda escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply
AT ergonulonder escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply
AT krauserobert escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply
AT martinquirosalejandro escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply
AT panopardojoseramon escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply
AT powernicholas escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply
AT sibanimarcella escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply
AT szabobalint escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply
AT tsiodrassotirios escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply
AT zollnerschwetzines escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply
AT rodriguezbanojesus escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply
AT escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply